You are here

Article Text

Article menu
Download PDFPDF
Clinical science
Original article
Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion
  1. Hidetaka Noma1,
  2. Hideharu Funatsu1,
  3. Tatsuya Mimura2,
  4. Shuichiro Eguchi3,
  5. Katsunori Shimada4
  1. 1Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, Chiba, Japan
  2. 2Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
  3. 3Department of Ophthalmology, Eguchi Eye Hospital, Hakodate, Japan
  4. 4Department of Hygiene and Public Health II, Tokyo Women's Medical University, Tokyo, Japan
  1. Correspondence to Hidetaka Noma, Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, 477-96, Owada-shinden, Yachiyo, Chiba 276-8524, Japan; nomahide{at}tymc.twmu.ac.jp

https://doi.org/10.1136/bjo.2010.192468

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Introduction

    Central retinal vein occlusion (CRVO) is a common retinal vascular disease that often causes macular …

    View Full Text

    Footnotes

    • Linked article 198002.

    • Competing interests None declared.

    • Ethics approval This study was conducted with the approval of the Tokyo Women's Medical University and Eguchi Eye Hospital.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles